Terms: = Breast cancer AND HMGA1, MGC4242, 3159, ENSG00000137309, MGC12816, HMGIY, P17096, MGC4854, HMG-R
94 results:
1. Targeting hmga1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
Chang X; Liu J; Yang Q; Gao Y; Ding X; Zhao J; Li Y; Liu Z; Li Z; Wu Y; Zuo D
Biochem Pharmacol; 2023 Jun; 212():115582. PubMed ID: 37146833
[TBL] [Abstract] [Full Text] [Related]
2. Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven breast cancer.
Gou X; Kim BJ; Anurag M; Lei JT; Young MN; Holt MV; Fandino D; Vollert CT; Singh P; Alzubi MA; Malovannaya A; Dobrolecki LE; Lewis MT; Li S; Foulds CE; Ellis MJ
Cancer Res; 2023 Oct; 83(19):3237-3251. PubMed ID: 37071495
[TBL] [Abstract] [Full Text] [Related]
3. Copy Number Variation in Inflammatory breast cancer.
Hazra A; O'Hara A; Polyak K; Nakhlis F; Harrison BT; Giordano A; Overmoyer B; Lynce F
Cells; 2023 Apr; 12(7):. PubMed ID: 37048158
[TBL] [Abstract] [Full Text] [Related]
4. Exosomal delivery of 7SK long non-coding RNA suppresses viability, proliferation, aggressiveness and tumorigenicity in triple negative breast cancer cells.
Farhadi S; Mohammadi-Yeganeh S; Kiani J; Hashemi SM; Koochaki A; Sharifi K; Ghanbarian H
Life Sci; 2023 Jun; 322():121646. PubMed ID: 37011870
[TBL] [Abstract] [Full Text] [Related]
5. High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions.
Lourenço AL; Chuo SW; Bohn MF; Hann B; Khan S; Yevalekar N; Patel N; Yang T; Xu L; Lv D; Drakas R; Lively S; Craik CS
MAbs; 2023; 15(1):2184197. PubMed ID: 36859773
[TBL] [Abstract] [Full Text] [Related]
6. hmga1 Regulates the Expression of Replication-Dependent Histone Genes and Cell-Cycle in breast cancer Cells.
Petrosino S; Pacor S; Pegoraro S; Gazziero VA; Canarutto G; Piazza S; Manfioletti G; Sgarra R
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614035
[TBL] [Abstract] [Full Text] [Related]
7. Recombinant human chorionic gonadotropin induces signaling pathways towards cancer prevention in the breast of BRCA1/2 mutation carriers.
Su Y; Dang NM; Depypere H; Santucci-Pereira J; Gutiérrez-Díez PJ; Kanefsky J; Janssens JP; Russo J
Eur J Cancer Prev; 2023 Mar; 32(2):126-138. PubMed ID: 35881946
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Significance of
Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
[TBL] [Abstract] [Full Text] [Related]
9. Identification of two cancer stem cell-like populations in triple-negative breast cancer xenografts.
Nakayama J; Matsunaga H; Arikawa K; Yoda T; Hosokawa M; Takeyama H; Yamamoto Y; Semba K
Dis Model Mech; 2022 Jun; 15(6):. PubMed ID: 35611554
[TBL] [Abstract] [Full Text] [Related]
10. hmga1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel.
Sgubin M; Pegoraro S; Pellarin I; Ros G; Sgarra R; Piazza S; Baldassarre G; Belletti B; Manfioletti G
Cell Death Dis; 2022 May; 13(5):429. PubMed ID: 35504904
[TBL] [Abstract] [Full Text] [Related]
11. Smartly responsive DNA-miRNA hybrids packaged in exosomes for synergistic enhancement of cancer cell apoptosis.
Zhang F; Isak AN; Yang S; Song Y; Ren L; Feng C; Chen G
Nanoscale; 2022 May; 14(17):6612-6619. PubMed ID: 35421879
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of Her2/Neu Oncoprotein in Serum and Tissue Samples in Women with breast cancer.
Pokhrel R; Yadav BK; Sharma N; Sharma VK; Tuladhar ET; Raut M; Bhattarai A; Dubey RK; Niraula A; Mishra A; Budhathoki U
Asian Pac J Cancer Prev; 2022 Feb; 23(2):429-433. PubMed ID: 35225453
[TBL] [Abstract] [Full Text] [Related]
13. EZH2-CCF-cGAS Axis Promotes breast cancer Metastasis.
Duan D; Shang M; Han Y; Liu J; Liu J; Kong SH; Hou J; Huang B; Lu J; Zhang Y
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163710
[TBL] [Abstract] [Full Text] [Related]
14. hmga1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location!
Pujals M; Resar L; Villanueva J
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572547
[TBL] [Abstract] [Full Text] [Related]
15. The synergy between miR-486-5p and tamoxifen causes profound cell death of tamoxifen-resistant breast cancer cells.
Mansoori B; Najafi S; Mohammadi A; AsadollahSeraj H; Savadi P; Mansoori B; Nazari A; Mokhtarzadeh A; Roshani E; Duijf PH; Cho WC; Baradaran B
Biomed Pharmacother; 2021 Sep; 141():111925. PubMed ID: 34323695
[TBL] [Abstract] [Full Text] [Related]
16. An image-based flow cytometric approach to the assessment of the nucleus-to-cytoplasm ratio.
Sebastian JA; Moore MJ; Berndl ESL; Kolios MC
PLoS One; 2021; 16(6):e0253439. PubMed ID: 34166419
[TBL] [Abstract] [Full Text] [Related]
17. Hsa_circ_0069094 knockdown inhibits cell proliferation, migration, invasion and glycolysis, while induces cell apoptosis by miR-661/hmga1 axis in breast cancer.
Sui C; Qu W; Lian Y; Feng C; Zhan Y
Anticancer Drugs; 2021 Sep; 32(8):829-841. PubMed ID: 33929992
[TBL] [Abstract] [Full Text] [Related]
18. Gene network analysis using SWIM reveals interplay between the transcription factor-encoding genes hmga1, FOXM1, and MYBL2 in triple-negative breast cancer.
Fiscon G; Pegoraro S; Conte F; Manfioletti G; Paci P
FEBS Lett; 2021 Jun; 595(11):1569-1586. PubMed ID: 33835503
[TBL] [Abstract] [Full Text] [Related]
19. Identification of mRNA and non-coding RNA hubs using network analysis in organ tropism regulated triple negative breast cancer metastasis.
Banerjee S; Kalyani Yabalooru SR; Karunagaran D
Comput Biol Med; 2020 Dec; 127():104076. PubMed ID: 33126129
[TBL] [Abstract] [Full Text] [Related]
20. Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancer.
Lin Y; Lin L; Fu F; Wang C; Hu A; Xie J; Jiang M; Wang Z; Yang L; Guo R; Yang P; Shen H
Breast Cancer Res Treat; 2021 Jan; 185(1):39-52. PubMed ID: 32920739
[TBL] [Abstract] [Full Text] [Related]
[Next]
